PBM Problems (Part 3): Monopoly Power in Prescription Drug Markets w/ Luke Slindee

We all know the cost of prescription drugs in the U.S. is a problem. How did we get here and what can we do about it?   This week, MTVA Board Members Dr. John Rodis and Dr. Steven Schutzer are joined by MTVA Executive Director Laura Wadsten for an engaging discussion with Senior Pharmacy Consultant ⁠Luke Slindee⁠, PharmD.  Luke is a second-generation pharmacist who has witnessed first-hand how hidden money flows and increasingly powerful players have hurt his fellow pharmacists, communities, and patients. He’s spent years studying the economics and power dynamics of the pharmacy supply chain, and in this episode he shares some solutions to these problems.  Tune in to learn more about the monopolies and oligopolies influencing drug costs, key differences in generic and brand markets, and how cash-only independent pharmacies can help solve this crisis. Check out the other episodes in our “PBM Problems” series:  Part 1 w/ ERISA Attorney Paul Holmes Part 2 w/ Mutual Rx CEO Roy Wilkinson ———————————— We’re excited to welcome like-minded organizations and individuals to join the new MTVA Membership program!  As a 501(c)(3) nonprofit, we rely on support from our grassroots network to advance our mission of creating a value-based health system with high-quality patient outcomes at a reasonable cost. We’re proud to offer two membership models, Ally Member and Trade Member. Tax-deductible membership contributions help us enrich the healthcare environment with quality content – including this podcast – and robust platforms to fuel discussion, collaboration, and advocacy that lead to ground-breaking solutions.  For more information and to join us, visit our website https://www.movingtovalue.org/membership. All episodes of MTVA Unscripted can be found⁠ ⁠here⁠⁠.